What if you'd held CUVL?
A $1,000 investment in Clinuvel Pharmaceuticals Limited (CUVL) at the month-end close of 2008-01 would be worth $2,000 at the close of 2026-09 — +100.0% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $7,979.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2008
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2008 | $1,000 | — |
| 2009 | $1,628 | +62.8% |
| 2010 | $1,415 | -13.1% |
| 2011 | $962 | -32.0% |
| 2012 | $1,258 | +30.8% |
| 2013 | $572 | -54.5% |
| 2014 | $2,150 | +275.8% |
| 2015 | $1,132 | -47.4% |
| 2016 | $3,327 | +193.9% |
| 2017 | $3,948 | +18.7% |
| 2018 | $8,120 | +105.6% |
| 2019 | $12,462 | +53.5% |
| 2020 | $10,654 | -14.5% |
| 2021 | $12,567 | +18.0% |
| 2022 | $9,322 | -25.8% |
| 2023 | $7,015 | -24.8% |
| 2024 | $4,901 | -30.1% |
| 2025 | $5,398 | +10.1% |
| 2026 | $4,150 | -23.1% |
Best and worst month-end to buy
The best single month-end close to have bought CUVL was 2013-12 ($0.90): $1,000 then is $7,253 today. The worst was 2021-09 ($29.94): $1,000 then is $218.
FAQ
What would $1,000 in CUVL be worth today?
A $1,000 investment in Clinuvel Pharmaceuticals Limited (CUVL) at the start of 2008 would be worth about $2,000 today, a total return of +100.0%. Dividends are reinvested in these figures.
What were the best and worst years for CUVL?
Clinuvel Pharmaceuticals Limited (CUVL)'s strongest calendar year since 2008 was 2014, a +275.8% return — $1,000 held through that year became about $3,758 by year-end. Its weakest year was 2013, at -54.5%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in CUVL have grown?
Investing $100 at the end of every month since 2008-01 would have grown to about $41,638 on $22,500 invested.
Did CUVL beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $7,979. CUVL trailed the S&P 500 by +74.9% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Clinuvel Pharmaceuticals Limited (CUVL) historical total-return data from 2008-01 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.